| |
NMOSD
|
control
|
|---|
|
Ln. IL-6 (pg/ml)
|
Ln.IL-17A(pg/ml)
|
Ln. IL-6 (pg/ml)
|
Ln.IL-17A(pg/ml)
|
|---|
|
rb
|
P-value
|
R
|
P-value
|
rb
|
P-value
|
r
|
P-value
|
|---|
|
Ln.insulin (μU/L)
|
0.32
|
0.03a
|
0.19
|
0.15
|
−0.05
|
0.75
|
−0.02
|
0.81
|
|
FBS (mg/dL)
|
0.11
|
0.54
|
0.003
|
0.98
|
0.07
|
0.66
|
0.16
|
0.10
|
|
Ln.TG (mg/dL)
|
0.34
|
0.02a
|
0.16
|
0.23
|
0.32
|
0.04a
|
0.34
|
0.001a
|
|
Ln.HDL (mg/dL)
|
−0.27
|
0.08
|
−0.02
|
0.88
|
−0.03
|
0.83
|
−0.06
|
0.56
|
|
LDL (mg/dL)
|
0.05
|
0.74
|
0.02
|
0.86
|
0.11
|
0.51
|
−0.008
|
0.93
|
|
Chol. (mg/dL)
|
0.003
|
0.98
|
0.03
|
0.84
|
0.16
|
0.34
|
0.10
|
0.32
|
|
Ln.AST (U/L)
|
0.12
|
0.44
|
0.19
|
0.18
|
−0.02
|
0.89
|
0.11
|
0.26
|
|
Ln.ALT (U/L)
|
−0.08
|
0.62
|
−0.03
|
0.81
|
0.06
|
0.73
|
−0.11
|
0.28
|
- a After adjusting with BMI, age and sex, there was constant significant correlation
- br: Pearson’s correlation was applied to determine the correlation between circulating markers and inflammatory markers in NMOSD patients and controls
- ALT alanine aminotransferase, SAT serum agglutination test, Chol total cholesterol, HDL high-density lipoprotein cholesterol, IL-6 interleukin −6, IL-17A interleukin-17A, LDL low-density lipoprotein, Ln natural log, TG triglyceride
